This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Carla Klattenhoff: Innovator in mRNA-mediated Immunization Methods
Introduction
Carla Klattenhoff is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of immunization through her innovative research and development of mRNA-mediated immunization methods. Her work focuses on generating antibodies using compositions that include cationic lipids and polynucleotide molecules.
Latest Patents
Carla holds 1 patent for her groundbreaking work titled "mRNA-mediated immunization methods." This patent outlines methods of immunization and the generation of antibodies using compositions that comprise cationic lipids and polynucleotide molecules, such as mRNA, which code for immunogens.
Career Highlights
Carla Klattenhoff has established herself as a key figure in the biotechnology sector. She is currently associated with Novartis AG, where she continues to advance her research in immunization technologies. Her innovative approaches have the potential to revolutionize vaccine development and enhance public health.
Collaborations
Throughout her career, Carla has collaborated with notable professionals in her field, including John Dominy and Robert W. Dunn. These collaborations have fostered a dynamic exchange of ideas and have contributed to the advancement of her research.
Conclusion
Carla Klattenhoff's contributions to mRNA-mediated immunization methods highlight her role as an influential inventor in the biotechnology industry. Her work not only showcases her innovative spirit but also emphasizes the importance of research in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile